13F FILER • LARRY ROBBINS

Glenview Capital Management

Larry Robbins — GLENVIEW CAPITAL MANAGEMENT, LLC

No writing by this manager has been read and indexed yet, so this page carries the filings only. Holdings come straight from the Form 13F-HR on EDGAR.

45

Positions

$5.5B

Reported Value

60.7%

In Top 10

—

Claims Indexed

Largest reported positions

GLENVIEW CAPITAL MANAGEMENT, LLC • CIK 0001138995 • 2026-06-30 • FILED 2026-08-14

WHAT CHANGED THIS QUARTER

In its Q2 2026 13F, filed Aug 14, 2026, Glenview Capital Management reported 45 positions worth $5.0B in US-listed stock. The largest stock position is Global Pmts Inc at 11.8% of the reported book, and the ten largest lines of any type make up 60.7% of it.

It opened 14 new positions, the largest stock positions being Agilent Technologies Inc ($261.6M), Eli Lilly & Co ($69.3M) and Mks Inc. ($43.8M), and exited 13, the largest stock exits being Dxc Technology Co ($111.8M last quarter), Zoominfo Technologies Inc ($95.1M last quarter) and Us Foods Hldg Corp ($35.4M last quarter).

Among positions it already held, the biggest increases by share count were Danaher Corp Del (+633%), Meta Platforms Inc (+191%) and Thermo Fisher Scientific Inc (+150%), and the biggest cuts were Applied Matls Inc (−67%), Advanced Micro Devices Inc (−54%) and Centene Corp Del (−41%).

Largest reported positions, quarter ended 2026-06-30
IssuerValueWeightShares QoQ
GLOBAL PMTS INC$646.3M11.8%+40%
CVS HEALTH CORP$499.1M9.1%-41%
TENET HEALTHCARE CORP$418.2M7.6%+47%
THERMO FISHER SCIENTIFIC INC$314.5M5.7%+150%
AMAZON COM INC$303.1M5.5%+20%
ISHARES TR (Put)$275.9M5.0%+145%
AGILENT TECHNOLOGIES INC$261.6M4.8%New
DANAHER CORP DEL$218.3M4.0%+633%
META PLATFORMS INC$201.0M3.7%+191%
STATE STR SPDR S&P 500 ETF T (Put)$194.2M3.5%New
ADVANCED MICRO DEVICES INC$173.3M3.2%-54%
TEVA PHARMACEUTICAL INDS LTD$172.1M3.1%-24%
VIATRIS INC$156.9M2.9%+9%
UBER TECHNOLOGIES INC$129.4M2.4%+23%
CENTENE CORP DEL$121.1M2.2%-41%
BUTTERFLY NETWORK INC$120.7M2.2%—
THE CIGNA GROUP$113.6M2.1%-17%
HUMANA INC$101.0M1.8%-24%
BLOCK INC$91.0M1.7%-12%
DICKS SPORTING GOODS INC$91.0M1.7%+34%

20 of 45 positions. 8.8% of reported value is options, where the figure is the notional value of the underlying rather than money spent. A 13F covers long US-listed positions at a quarter end only — no shorts, leverage, cash, ordinary bonds or private holdings — and is 45 days old on publication.

NEW POSITIONS

  • Agilent Technologies Inc$261.6M · 4.8%
  • Eli Lilly & Co$69.3M · 1.3%
  • Mks Inc.$43.8M · 0.8%
  • Stmicroelectronics N V$41.9M · 0.8%
  • Abbvie Inc$37.5M · 0.7%

EXITS

  • Dxc Technology Co$111.8M last quarter
  • Zoominfo Technologies Inc$95.1M last quarter
  • Us Foods Hldg Corp$35.4M last quarter
  • Zillow Group Inc$32.7M last quarter
  • Lithia Mtrs Inc$31.9M last quarter

QUESTIONS PEOPLE ASK

What are Glenview Capital Management's largest holdings?

OPEN
As of Jun 30, 2026, the three largest stock positions are Global Pmts Inc (11.8%), Cvs Health Corp (9.1%) and Tenet Healthcare Corp (7.6%), together 28.5% of the reported book.

How big is Glenview Capital Management's 13F portfolio?

OPEN
The Q2 2026 13F, filed Aug 14, 2026, reports 45 positions worth $5.5B. The ten largest make up 60.7% of it. 8.8% of that value is options, reported at the notional value of the underlying rather than money spent.

What did Glenview Capital Management buy and sell in Q2 2026?

OPEN
It opened 14 new positions, the largest stock positions being Agilent Technologies Inc ($261.6M), Eli Lilly & Co ($69.3M) and Mks Inc. ($43.8M), and exited 13, the largest stock exits being Dxc Technology Co ($111.8M last quarter), Zoominfo Technologies Inc ($95.1M last quarter) and Us Foods Hldg Corp ($35.4M last quarter). Among positions it already held, the biggest increases by share count were Danaher Corp Del (+633%), Meta Platforms Inc (+191%) and Thermo Fisher Scientific Inc (+150%), and the biggest cuts were Applied Matls Inc (−67%), Advanced Micro Devices Inc (−54%) and Centene Corp Del (−41%).

When is Glenview Capital Management's next 13F due?

OPEN
The Q3 2026 13F is due Nov 16, 2026. Forty-five days after the quarter ends is November 14, 2026 (Saturday), so the deadline moves to the next business day. Larry Robbins' filing usually lands close to the deadline.

Filers with overlapping books